MediMedia Managed Markets
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager

Statement of Purpose
Guidelines for Authors
Editorial Board

Recent Issues

March 2007


Anticholinergic Medications for the Treatment of Chronic Obstructive Pulmonary Disease

The author summarizes the efficacy of two inhaled agents—ipratropium bromide (Atrovent HFA) and tiotropium bromide (Spiriva)—in reducing dyspnea, bronchoconstriction, the frequency of disease exacerbation, and in improving patients’ health status.
Daren L. Knoell, MD

Meeting Highlights

American College of Gastroenterology: 2006 Annual Scientific Meeting and Postgraduate Course

Two biologic agents are featured: infliximab (Remicade), which is approved for the treatment of ulcerative colitis, and adalimumab (Humira), indicated for patients with Crohn’s disease.
Walter Alexander

Pharmaceutical Approval Update

The author discusses paliperidone (Invega) for the treatment of schizophrenia; telbivudine (Tyzeka) for patients with chronic hepatitis B infection; and a combination of clindamycin phosphate and tretinoin (Ziana Gel) as a topical therapy for acne vulgaris.
Marvin M. Goldenberg, PhD, RPh, MS

Continuing Education Credit

Depression in the Elderly

Geriatric depression is often overlooked. The authors review the epidemiology, diagnosis, pathophysiology, and treatment of depression in older adults, with an emphasis on newer pharmacotherapeutic agents.
Richard B. Birrer, MD, Michael DeLisi, MD, and Talin Arsen Dadoyan, MD



Medicare and P4P

David Nash, MD, MBA, discusses the Institute of Medicine’s recommendations for a national P4P program for the entire Medicare system.
David B. Nash, MD, MBA

Medication Errors

How Fast Is Too Fast for Delivering IV Push Medications?

Matthew Grissinger, RPh, FASCP, explains how injecting medications too rapidly can harm patients.
Matthew Grissinger, RPh, FASCP

Prescription: Washington

New FDA Drug Safety Initiatives: Does the Agency Have Enough Money and Authority?

Stephen Barlas discusses some of the challenges that lie ahead at the FDA when Congress reauthorizes the Prescription Drug Users Fee Act, which expires in June.
Stephen Barlas

New Drugs/Drug News/New Medical Devices

P&T presents the latest studies and information about FDA approvals, drug indications, industry updates, and new devices.

Drug Forecast

Conivaptan HCl for Injection (Vaprisol): A Vasopressin Antagonist for the Management of Euvolemic Hyponatremia

The author reviews conivaptan HCl injection (Vaprisol) for the treatment of euvolemic hyponatremia.
Larisa Chagan, PharmD, BCPS